Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease
Open Access
- 19 January 2021
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 11 (1), 126
- https://doi.org/10.3390/biom11010126
Abstract
So far, there is no effective disease-modifying therapies for Alzheimer’s Disease (AD) in clinical practice. In this context, glycine-L-proline-L-glutamate (GPE) and its analogs may open the way for developing a novel molecule for treating neurodegenerative disorders, including AD. In turn, this study was aimed to investigate the neuroprotective potentials exerted by three novel GPE peptidomimetics (GPE1, GPE2, and GPE3) using an in vitro AD model. Anti-Alzheimer potentials were determined using a wide array of techniques, such as measurements of mitochondrial viability (MTT) and lactate dehydrogenase (LDH) release assays, determination of acetylcholinesterase (AChE), α-secretase and β-secretase activities, comparisons of total antioxidant capacity (TAC) and total oxidative status (TOS) levels, flow cytometric and microscopic detection of apoptotic and necrotic neuronal death, and investigating gene expression responses via PCR arrays involving 64 critical genes related to 10 different pathways. Our analysis showed that GPE peptidomimetics modulate oxidative stress, ACh depletion, α-secretase inactivation, apoptotic, and necrotic cell death. In vitro results suggested that treatments with novel GPE analogs might be promising therapeutic agents for treatment and/or or prevention of AD.This publication has 58 references indexed in Scilit:
- Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairmentBMC Complementary and Alternative Medicine, 2013
- Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional ProfilingPLOS ONE, 2013
- Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toona sinensis on human cancer cellsCancer Cell International, 2013
- Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to l-dopa in a Parkinson’s animal modelAmino Acids, 2012
- Insulin-degrading enzyme is exported via an unconventional protein secretion pathwayMolecular Neurodegeneration, 2009
- The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative diseaseMolecular Neurodegeneration, 2009
- Rosuvastatin reduces caspase-3 activity and up-regulates α-secretase in human neuroblastoma SH-SY5Y cells exposed to AβNeuroscience Letters, 2004
- Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I ProtectionOnline Journal of Public Health Informatics, 2002
- β-Amyloid-Induced Endothelial Necrosis and Inhibition of Nitric Oxide ProductionExperimental Cell Research, 1997
- Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptideBiochemical and Biophysical Research Communications, 1989